THE US Food and Drug
Administration has announced the
launch of a new scheme which
aims to help health care providers
detect and report misleading
promotions for medications.
The educational outreach effort is
administered by the FDA’s Division
of Drug Marketing, Advertising and
Communications (DDMAC), and
aims to get health providers to blow
the whistle on inappropriate
promotional activities that occur in
private - complementing other
activities which see the agency
monitor large medical conventions
and industry complaints.
Reports can be submitted
anonymously to a special email
address at badad@fda.gov or
through a telephone hotline.The above article was sent to subscribers in Pharmacy Daily's issue from 12 May 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 May 10
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.